Novartis announces mutual agreement to terminate sale of Sandoz US generic oral solids, dermatology portfolio to Aurobindo Read more
Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies Read more
ImmunityBio Combines Supercomputing Power with Microsoft Azure to Target Infection “Doorway” of the Coronavirus Read more
Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for ARDS Associated with COVID-19 Read more
Lilly and Sitryx Announce Licensing and Research Collaboration to Discover and Develop New Immunometabolic Medicines Read more
VBI Vaccines Announces Tie-up To Develop Pan-Coronavirus Vaccine Candidate Targeting COVID-19, SARS, and MERS Read more